Vaccine Adjuvants Global Market Report 2024

Vaccine Adjuvants Global Market Report 2024

Including: 1) By Product Type: Adjuvant Emulsions; Pathogen Components; Particulate Adjuvants; Combination Adjuvants2) By Route of Application: Human Vaccine Adjuvants; Veterinary Vaccine Adjuvants3) By Route of Administration: Oral; Intramuscular; Intranasal; Subcutaneous; Intradermal4) By Disease: Cancer; Infectious DiseasesCovering: GlaxoSmithKline Plc.; Novavax Inc.; SPI Pharma Inc.; Agenus Inc.; CSL Limited


Vaccine Adjuvants Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vaccine adjuvants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for vaccine adjuvants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vaccine adjuvants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Product Type: Adjuvant Emulsions; Pathogen Components; Particulate Adjuvants; Combination Adjuvants; Other Product Types

2) By Route of Application: Human Vaccine Adjuvants; Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral; Intramuscular; Intranasal; Subcutaneous; Intradermal

4) By Disease: Cancer; Infectious Diseases; Other Diseases

Companies Mentioned: GlaxoSmithKline Plc.; Novavax Inc.; SPI Pharma Inc.; Agenus Inc.; CSL Limited

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Vaccine Adjuvants Market Characteristics
3. Vaccine Adjuvants Market Trends And Strategies
4. Vaccine Adjuvants Market - Macro Economic Scenario
4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market
5. Global Vaccine Adjuvants Market Size and Growth
5.1. Global Vaccine Adjuvants Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Vaccine Adjuvants Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Vaccine Adjuvants Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Vaccine Adjuvants Market Segmentation
6.1. Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Adjuvant Emulsions
Pathogen Components
Particulate Adjuvants
Combination Adjuvants
Other Product Types
6.2. Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Human Vaccine Adjuvants
Veterinary Vaccine Adjuvants
6.3. Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Intramuscular
Intranasal
Subcutaneous
Intradermal
6.4. Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cancer
Infectious Diseases
Other Diseases
7. Vaccine Adjuvants Market Regional And Country Analysis
7.1. Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Vaccine Adjuvants Market
8.1. Asia-Pacific Vaccine Adjuvants Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Vaccine Adjuvants Market
9.1. China Vaccine Adjuvants Market Overview
9.2. China Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Vaccine Adjuvants Market
10.1. India Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Vaccine Adjuvants Market
11.1. Japan Vaccine Adjuvants Market Overview
11.2. Japan Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Vaccine Adjuvants Market
12.1. Australia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Vaccine Adjuvants Market
13.1. Indonesia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Vaccine Adjuvants Market
14.1. South Korea Vaccine Adjuvants Market Overview
14.2. South Korea Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Vaccine Adjuvants Market
15.1. Western Europe Vaccine Adjuvants Market Overview
15.2. Western Europe Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Vaccine Adjuvants Market
16.1. UK Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Vaccine Adjuvants Market
17.1. Germany Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Vaccine Adjuvants Market
18.1. France Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Vaccine Adjuvants Market
19.1. Italy Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Vaccine Adjuvants Market
20.1. Spain Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Vaccine Adjuvants Market
21.1. Eastern Europe Vaccine Adjuvants Market Overview
21.2. Eastern Europe Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Vaccine Adjuvants Market
22.1. Russia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Vaccine Adjuvants Market
23.1. North America Vaccine Adjuvants Market Overview
23.2. North America Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Vaccine Adjuvants Market
24.1. USA Vaccine Adjuvants Market Overview
24.2. USA Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Vaccine Adjuvants Market
25.1. Canada Vaccine Adjuvants Market Overview
25.2. Canada Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Vaccine Adjuvants Market
26.1. South America Vaccine Adjuvants Market Overview
26.2. South America Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Vaccine Adjuvants Market
27.1. Brazil Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Vaccine Adjuvants Market
28.1. Middle East Vaccine Adjuvants Market Overview
28.2. Middle East Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Vaccine Adjuvants Market
29.1. Africa Vaccine Adjuvants Market Overview
29.2. Africa Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Vaccine Adjuvants Market Competitive Landscape And Company Profiles
30.1. Vaccine Adjuvants Market Competitive Landscape
30.2. Vaccine Adjuvants Market Company Profiles
30.2.1. GlaxoSmithKline Plc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Novavax Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. SPI Pharma Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Agenus Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. CSL Limited
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Vaccine Adjuvants Market Competitive Benchmarking
32. Global Vaccine Adjuvants Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Vaccine Adjuvants Market
34. Vaccine Adjuvants Market Future Outlook and Potential Analysis
34.1 Vaccine Adjuvants Market In 2028 - Countries Offering Most New Opportunities
34.2 Vaccine Adjuvants Market In 2028 - Segments Offering Most New Opportunities
34.3 Vaccine Adjuvants Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings